SCHEMBL9224043

SCHEMBL9224043

COc1nccnc1C1CN2CCC1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethane SCHEMBL9442733 0.98
SCHEMBL9224566 0.85
Hydrochloric Acid SCHEMBL9225416 0.84
SCHEMBL9224545 0.82
Hydrochloric Acid SCHEMBL9230266 0.81
SCHEMBL9226821 0.81
SCHEMBL9230662 0.80
Hydrochloric Acid SCHEMBL9228131 0.80
Hydrochloric Acid SCHEMBL9231030 0.79
SCHEMBL9228025 0.79 CHRM1 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0521067-B1 AZACYCLIC OR AZABICYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1995-06-28 EP claimed
US-5182283-A Alzheimer's disease NOVO NORDISK A/S (DK) 1993-01-26 US claimed
EP-0521067-A1 AZACYCLIC OR AZABICYCLIC COMPOUNDS, THEIR PREPARATION AND USE. NOVO NORDISK AS (DK) 1993-01-07 EP claimed
WO-1991014686-A1 AZACYCLIC OR AZABICYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1991-10-03 WO claimed
EP-0521067-B1 AZACYCLIC OR AZABICYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1995-06-28 EP disclosed
US-5182283-A Alzheimer's disease NOVO NORDISK A/S (DK) 1993-01-26 US disclosed
WO-1991014686-A1 AZACYCLIC OR AZABICYCLIC COMPOUNDS, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1991-10-03 WO disclosed